［1］Parkin D M，Bray F，Ferlay J，et al.Global cancer statistics，2002.CA Cancer J Clin，2005，55（2）：74－108.

［2］Pisani P，Parkin D M，Bray F，et al.Erratum：Estimates of the worldwide mortality from 25cancers in 1990.Int J Cancer，1999，83（6）：870－873.

［3］Haidari M，Nikbakht M R，Pasdar Y，et al.Trend analysis of gastric cancer incidence in Iran and its six geographical areas during 2000－2005.Asian Pac J Cancer Prev，2012，13（7）：3335－3341.

［4］Jemal A，Bray F，Center M M，et al.Global cancer statistics.CA Cancer J Clin，2011，61（2）：69－90.

［5］Price T J，Shapiro J D，Segelov E，et al.Management of advanced gastric cancer.Expert Rev Gastroenterol Hepatol，2012，6（2）：199－208，209.

［6］Hanahan D，Weinberg R A.Hallmarks of cancer：the next generation.Cell，2011，144（5）：646－674.

［7］Hanahan D，Weinberg R A.The hallmarks of cancer.Cell，2000，100（1）：57－70.

［8］Ponder B A.Cancer genetics.Nature，2001，411（6835）：336－341.

［9］Wang K，Kan J，Yuen S T，et al.Exome sequencing identifies frequent mutation of ARID1Ain molecular subtypes of gastric cancer.Nat Genet，2011，43（12）：1219－1223.

［10］Mousavi S M，Gouya M M，Ramazani R，et al.Cancer incidence and mortality in Iran.Ann Oncol，2009，20（3）：556－563.

［11］Eskandar H，Hossein S S，Rahim M，et al.Clinical profile of gastric cancer in Khuzestan，southwest of Iran.World J Gastroenterol，2006，12（30）：4832－4835.

［12］Ghadimi R，Taheri H，Suzuki S，et al.Host and environmental factors for gastric cancer in Babol，the Caspian Sea Coast，Iran.Eur J Cancer Prev，2007，16（3）：192－195.

［13］Chandanos E，Lagergren J.Oestrogen and the enigmatic male predominance of gastric cancer.Eur J Cancer，2008，44（16）：2397－2403.

［14］Malekzadeh R，Sotoudeh M，Derakhshan M H，et al.Prevalence of gastric precancerous lesions in Ardabil，a high incidence province for gastric adenocarcinoma in the northwest of Iran.J Clin Pathol，2004，57（1）：37－42.

［15］Malekzadeh R，Derakhshan M H，Malekzadeh Z.Gastric cancer in Iran：epidemiology and risk factors.Arch Iran Med，2009，12（6）：576－583.

［16］Sadjadi A，Hislop T G，Bajdik C，et al.Comparison of breast cancer survival in two populations：Ardabil，Iran and British Columbia，Canada.BMC Cancer，2009，9：381.

［17］Saeki N，Ono H，Sakamoto H，et al.Genetic factors related to gastric cancer susceptibility identified using agenome－wide association study.Cancer Sci，2013，104（1）：1－8.

［18］Coupland V H，Lagergren J，Konfortion J，et al.Ethnicity in relation to incidence of oesophageal and gastric cancer in England.Br J Cancer，2012，107（11）：1908－1914.

［19］Sasazuki S，Sasaki S，Tsugane S.Cigarette smoking，alcohol consumption and subsequent gastric cancer risk by subsite and histologic type.Int J Cancer，2002，101（6）：560－566.

［20］Steevens J，Schouten L J，Goldbohm R A，et al.Alcohol consumption，cigarette smoking and risk of subtypes of oesophageal and gastric cancer：aprospective cohort study.Gut，2010，59（1）：39－48.

［21］Bertuccio P，Chatenoud L，Levi F，et al.Recent patterns in gastric cancer：aglobal overview.Int J Cancer，2009，125（3）：666－673.

［22］Sjodahl K，Lu Y，Nilsen T I，et al.Smoking and alcohol drinking in relation to risk of gastric cancer：a population－based，prospective cohort study.Int J Cancer，2007，120（1）：128－132.

［23］Shin V Y，Cho C H.Nicotine and gastric cancer.Alcohol，2005，35（3）：259－264.

［24］Huang R Y，Chen G G.Cigarette smoking，cyclooxygenase－2pathway and cancer.Biochim Biophys Acta，2011，1815（2）：158－169.

［25］Zhang Y，Sun L P，Xing C Z，et al.Interaction between GSTP1Val allele and H.pylori infection，smoking and alcohol consumption and risk of gastric cancer among the Chinese population.PLoS One，2012， 7（10）：e47178.

［26］Everatt R，Tamosiunas A，Kuzmickiene I，et al.Alcohol consumption and risk of gastric cancer：a cohort study of men in Kaunas，Lithuania，with up to 30years follow－up.BMC Cancer，2012，12：475.

［27］Moy K A，Fan Y，Wang R，et al.Alcohol and tobacco use in relation to gastric cancer：aprospective study of men in Shanghai，China.Cancer Epidemiol Biomarkers Prev，2010，19（9）：2287－2297.

［28］Duell E J，Travier N，Lujan－Barroso L，et al.Alcohol consumption and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition（EPIC）cohort.Am J Clin Nutr，2011，94（5）：1266－1275.

［29］Tramacere I，Negri E，Pelucchi C，et al.A meta－analysis on alcohol drinking and gastric cancer risk.Ann Oncol，2012，23（1）：28－36.

［30］Klatsky A L.Diet，alcohol，and health：a story of connections，confounders，and cofactors.Am J Clin Nutr，2001，74（3）：279－280.

［31］Ding W Q，Fried U，Larsson C，et al.Ethanol exposure potentiates fosB and junB expression induced by muscarinic receptor stimulation in neuroblastoma SH－SY5Ycells.Alcohol Clin Exp Res，1998，22（1）：225－230.

［32］Huang B，Liu B，Yang L，et al.Functional genetic variants of c－Jun and their interaction with smoking and drinking increase the susceptibility to lung cancer in southern and eastern Chinese.Int J Cancer，2012，131（5）：E744－E758.

［33］Chang Y J，Wu M S，Lin J T，et al.Helicobacter pylori－Induced invasion and angiogenesis of gastric cells is mediated by cyclooxygenase－2induction through TLR2／TLR9and promoter regulation.J Immunol，2005，175（12）：8242－8252.

［34］Gajalakshmi C K，Shanta V.Lifestyle and risk of stomach cancer：a hospital－based case－control study.Int J Epidemiol，1996，25（6）：1146－1153.

［35］Chow W H，Swanson C A，Lissowska J，et al.Risk of stomach cancer in relation to consumption of cigarettes，alcohol，tea and coffee in Warsaw，Poland.Int J Cancer，1999，81（6）：871－876.

［36］Wu A H，Wan P，Bernstein L.A multiethnic population－based study of smoking，alcohol and body size and risk of adenocarcinomas of the stomach and esophagus（United States）.Cancer Causes Control，2001，12（8）：721－732.

［37］Rao D N，Ganesh B，Dinshaw K A，et al.A case－control study of stomach cancer in Mumbai，India.Int J Cancer，2002，99（5）：727－731.

［38］Barstad B，Sorensen T I，Tjonneland A，et al.Intake of wine，beer and spirits and risk of gastric cancer.Eur J Cancer Prev，2005，14（3）：239－243.

［39］Larsson S C，Giovannucci E，Wolk A.Alcoholic beverage consumption and gastric cancer risk：aprospective population－based study in women.Int J Cancer，2007，120（2）：373－377.

［40］Kaneko S，Yoshimura T.Time trend analysis of gastric cancer incidence in Japan by histological types，1975－1989.Br J Cancer，2001，84（3）：400－405.

［41］D′Elia L，Rossi G，Ippolito R，et al.Habitual salt intake and risk of gastric cancer：a meta－analysis of prospective studies.Clin Nutr，2012，31（4）：489－498.

［42］Zhong C，Li K N，Bi J W，et al.Sodium intake，salt taste and gastric cancer risk according to helicobacter pylori infection，smoking，histological type and tumor site in china.Asian Pac J Cancer Prev，2012，13 （6）：2481－2484.

［43］Kim J，Park S，Nam B H.Gastric cancer and salt preference：apopulation－based cohort study in Korea.Am J Clin Nutr，2010，91（5）：1289－1293.

［44］Xiao S D，Jiang S J，Wang R N，et al.N－ethyl－N′－nitro－N－nitrosoguanidine induced gastric carcinoma in wolfdogs－－useful animal model for tracing gastric malignancy transformation.Chin Med J（Engl），1986，99（11）：903－907.

［45］Moret S，Conte L，Dean D.Assessment of polycyclic aromatic hydrocarbon content of smoked fish by means of a fast HPLC／HPLC method.J Agric Food Chem，1999，47（4）：1367－1371.

［46］Lopez－Carrillo L，Lopez－Cervantes M，Ward M H，et al.Nutrient intake and gastric cancer in Mexico.Int J Cancer，1999，83（5）：601－605.

［47］Azevedo L F，Salgueiro L F，Claro R，et al.Diet and gastric cancer in Portugal－－a multivariate model.Eur J Cancer Prev，1999，8（1）：41－48.

［48］Chen J，Bu X L，Wang Q Y，et al.Decreasing seroprevalence of Helicobacter pylori infection during 1993－2003in Guangzhou，southern China.Helicobacter，2007，12（2）：164－169.

［49］Kawakami E，Machado R S，Ogata S K，et al.Decrease in prevalence of Helicobacter pylori infection during a 10－year period in Brazilian children.Arq Gastroenterol，2008，45（2）：147－151.

［50］Tkachenko M A，Zhannat N Z，Erman L V，et al.Dramatic changes in the prevalence of Helicobacter pylori infection during childhood：a 10－year follow－up study in Russia.J Pediatr Gastroenterol Nutr，2007，45（4）：428－432.

［51］La Vecchia C，Negri E，D′Avanzo B，et al.Electric refrigerator use and gastric cancer risk.Br J Cancer，1990，62（1）：136－137.

［52］Katz L，Steinitz R.Cancer patterns in Israel：selected aspects.Isr J Med Sci，1979，15（12）：983－989.

［53］Demirer T，Icli F，Uzunalimoglu O，et al.Diet and stomach cancer incidence.A case－control study in Turkey.Cancer，1990，65（10）：2344－2348.

［54］Kim H J，Chang W K，Kim M K，et al.Dietary factors and gastric cancer in Korea：a case－control study.Int J Cancer，2002，97（4）：531－535.

［55］Matsuzaka M，Fukuda S，Takahashi I，et al.The decreasing burden of gastric cancer in Japan.Tohoku J Exp Med，2007，212（3）：207－219.

［56］Zhou Y，Zhuang W，Hu W，et al.Consumption of large amounts of Allium vegetables reduces risk for gastric cancer in a meta－analysis.Gastroenterology，2011，141（1）：80－89.

［57］Terry P，Lagergren J，Hansen H，et al.Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers.Eur J Cancer Prev，2001，10（4）：365－369.

［58］Kim M K，Sasaki S，Sasazuki S，et al.Prospective study of three major dietary patterns and risk of gastric cancer in Japan.Int J Cancer，2004，110（3）：435－442.

［59］Yang C S，Lee M J，Chen L，et al.Polyphenols as inhibitors of carcinogenesis.Environ Health Perspect，1997，105（Suppl 4）：971－976.

［60］Weisburger J H，Chung F L.Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols.Food Chem Toxicol，2002，40（8）：1145－1154.

［61］Kono S，Ikeda M，Tokudome S，et al.A case－control study of gastric cancer and diet in northern Kyushu，Japan.Jpn J Cancer Res，1988，79（10）：1067－1074.

［62］Ikeda F，Doi Y，Yonemoto K，et al.Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection：apopulation－based cohort study.Gastroenterology，2009，136（4）：1234－1241.

［63］Chen Y L，Cheng K C，Lai S W，et al.Diabetes and risk of subsequent gastric cancer：apopulation－based cohort study in Taiwan.Gastric Cancer，2013，16（3）：389－396.

［64］An international association between Helicobacter pylori infection and gastric cancer.The EUROGAST Study Group.Lancet，1993，341（8857）：1359－1362.

［65］Gonzalez C A，Agudo A.Carcinogenesis，prevention and early detection of gastric cancer：where we are and where we should go.Int J Cancer，2012，130（4）：745－753.

［66］Oliveira A G，Santos A，Guerra J B，et al.babA2－and cagA－positive Helicobacter pylori strains are associated with duodenal ulcer and gastric carcinoma in Brazil.J Clin Microbiol，2003，41（8）：3964－3966.

［67］Al－Marhoon M S，Nunn S，Soames R W.The association between cagA＋H.pylori infection and distal gastric cancer：aproposed model.Dig Dis Sci，2004，49（7－8）：1116－1122.

［68］Pirzadeh A，Doustmohammadian N，Khoshbaten M，et al.Is there any association between Helicobacter Pylori infection and laryngeal carcinoma？Asian Pac J Cancer Prev，2011，12（4）：897－900.

［69］Wong B C，Lam S K，Wong W M，et al.Helicobacter pylori eradication to prevent gastric cancer in a high－risk region of China：a randomized controlled trial.JAMA，2004，291（2）：187－194.

［70］Guilford P，Hopkins J，Harraway J，et al.E－cadherin germline mutations in familial gastric cancer.Nature，1998，392（6674）：402－405.

［71］Kato M，Asaka M.Recent development of gastric cancer prevention.Jpn J Clin Oncol，2012，42（11）：987－994.

［72］Haruma K.Trend toward a reduced prevalence of Helicobacter pylori infection，chronic gastritis，and gastric cancer in Japan.Gastroenterol Clin North Am，2000，29（3）：623－631.

［73］Fukase K，Kato M，Kikuchi S，et al.Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer：an open－label，randomised controlled trial.Lancet，2008，372（9636）：392－397.

［74］Held M，Engstrand L，Hansson L E，et al.Is the association between Helicobacter pylori and gastric cancer confined to CagA－positive strains？Helicobacter，2004，9（3）：271－277.

［75］Ohnishi N，Yuasa H，Tanaka S，et al.Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse.Proc Natl Acad Sci U S A，2008，105（3）：1003－1008.

［76］Chaturvedi R，Asim M，Romero－Gallo J，et al.Spermine oxidase mediates the gastric cancer risk associated with Helicobacter pylori CagA.Gastroenterology，2011，141（5）：1696－1708.

［77］Asahi M，Azuma T，Ito S，et al.Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells.J Exp Med，2000，191（4）：593－602.

［78］Konturek P C，Konturek S J，Brzozowski T.Helicobacter pylori infection in gastric cancerogenesis.J Physiol Pharmacol，2009，60（3）：3－21.

［79］Galmiche A，Rassow J，Doye A，et al.The N－terminal 34kDa fragment of Helicobacter pylori vacuolating cytotoxin targets mitochondria and induces cytochrome c release.EMBO J，2000，19（23）：6361－6370.

［80］Yuan J P，Li T，Chen H B，et al.Analysis of gene expression profile in gastric cancer cells stimulated with Helicobacter pylori isogenic strains.J Med Microbiol，2004，53（Pt 10）：965－974.

［81］Yamaoka Y，Kikuchi S，El－Zimaity H M，et al.Importance of Helicobacter pylori oipA in clinical presentation，gastric inflammation，and mucosal interleukin 8production.Gastroenterology，2002，123（2）：414－424.

［82］Kidd M，Peek R M，Lastovica A J，et al.Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease.Gut，2001，49（5）：629－635.

［83］Koehler C I，Mues M B，Dienes H P，et al.Helicobacter pylori genotyping in gastric adenocarcinoma and MALT lymphoma by multiplex PCR analyses of paraffin wax embedded tissues.Mol Pathol，2003，56 （1）：36－42.

［84］Sureka C，Ramesh T.Molecular assessment of c－H－ras p21expression in Helicobacter pylori－mediated gastric carcinogenesis.Mol Cell Biochem，2012，362（1－2）：169－176.

［85］Imazeki F，Omata M，Nose H，et al.p53gene mutations in gastric and esophageal cancers.Gastroenterology，1992，103（3）：892－896.

［86］Perri F，Cotugno R，Piepoli A，et al.Aberrant DNA methylation in non－neoplastic gastric mucosa of H.Pylori infected patients and effect of eradication.Am J Gastroenterol，2007，102（7）：1361－1371.

［87］Honig A，Witte F，Mirecka J，et al.Helicobacter pylori－induced hyperproliferation：relevance for gastric cancer development in connection with mutagenic factors.Anticancer Res，2000，20（3A）：1641－1648.

［88］Lynch D A，Mapstone N P，Clarke A M，et al.Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy.Gut，1995，36（3）：346－350.

［89］Suzuki N，Wakasugi M，Nakaya S，et al.Production and application of new monoclonal antibodies specific for a fecal Helicobacter pylori antigen.Clin Diagn Lab Immunol，2002，9（1）：75－78.

［90］Beswick E J，Pinchuk I V，Suarez G，et al.Helicobacter pylori CagA－dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74and stimulates procarcinogenic events.J Immunol，2006，176（11）：6794－6801.

［91］Wang J，Fan X，Lindholm C，et al.Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas／Fas ligand interactions.Infect Immun，2000，68（7）：4303－4311.

［92］郭燕，周新家.HP感染与胃癌组织中Caspase－3表达的关系.山东医药，2008，48（36）：76－77.

［93］Targosz A，Brzozowski T，Pierzchalski P，et al.Helicobacter pylori promotes apoptosis，activates cyclooxygenase（COX）－2and inhibits heat shock protein HSP70in gastric cancer epithelial cells.Inflamm Res，2012，61（9）：955－966.

［94］Chang C S，Chen W N，Lin H H，et al.Increased oxidative DNA damage，inducible nitric oxide synthase，nuclear factor kappaB expression and enhanced antiapoptosis－related proteins in Helicobacter pylori－infected non－cardiac gastric adenocarcinoma.World J Gastroenterol，2004，10（15）：2232－2240.

［95］Wu C Y，Wang C J，Tseng C C，et al.Helicobacter pylori promote gastric cancer cells invasion through a NF－kappaB and COX－2－mediated pathway.World J Gastroenterol，2005，11（21）：3197－3203.

［96］Hou L，Savage S A，Blaser M J，et al.Telomere length in peripheral leukocyte DNA and gastric cancer risk.Cancer Epidemiol Biomarkers Prev，2009，18（11）：3103－3109.

［97］Nardone G，Staibano S，Rocco A，et al.Effect of Helicobacter pylori infection and its eradication on cell proliferation，DNA status，and oncogene expression in patients with chronic gastritis.Gut，1999，44（6）：789－799.

［98］Cheng Y，Chaturvedi R，Asim M，et al.Helicobacter pylori－induced macrophage apoptosis requires activation of ornithine decarboxylase by c－Myc.J Biol Chem，2005，280（23）：22492－22496.

［99］Wang J，Chi D S，Kalin G B，et al.Helicobacter pylori infection and oncogene expressions in gastric carcinoma and its precursor lesions.Dig Dis Sci，2002，47（1）：107－113.

［100］Churin Y，Al－Ghoul L，Kepp O，et al.Helicobacter pylori CagA protein targets the c－Met receptor and enhances the motogenic response.J Cell Biol，2003，161（2）：249－255.

［101］Kabir S.Effect of Helicobacter pylori eradication on incidence of gastric cancer in human and animal models：underlying biochemical and molecular events.Helicobacter，2009，14（3）：159－171.

［102］Shirin H，Sordillo E M，Kolevska T K，et al.Chronic Helicobacter pylori infection induces an apoptosis－resistant phenotype associated with decreased expression of p27（kip1）.Infect Immun，2000，68（9）：5321－5328.

［103］石巍，姚育红，廖爱军，等.不同胃黏膜病变中幽门螺杆菌感染与环氧合酶表达相关性分析.中华消化杂志，2004，24（12）：750－751.

［104］Nam K T，Hahm K B，Oh S Y，et al.The selective cyclooxygenase－2inhibitor nimesulide prevents Helicobacter pylori－associated gastric cancer development in a mouse model.Clin Cancer Res，2004，10 （23）：8105－8113.

［105］Iwamoto J，Mizokami Y，Takahashi K，et al.The effects of cyclooxygenase2－prostaglandinE2pathway on Helicobacter pylori－induced urokinase－type plasminogen activator system in the gastric cancer cells.Helicobacter，2008，13（3）：174－182.

［106］Konturek P C，Kania J，Kukharsky V，et al.Influence of gastrin on the expression of cyclooxygenase－2，hepatocyte growth factor and apoptosis－related proteins in gastric epithelial cells.J Physiol Pharmacol，2003，54（1）：17－32.

［107］Walduck A K，Weber M，Wunder C，et al.Identification of novel cyclooxygenase－2－dependent genes in Helicobacter pylori infection in vivo.Mol Cancer，2009，8：22.

［108］林瑞新，任辉，田立业，等.Hp阳性胃癌患者PG及胃泌素水平的研究.中国实验诊断学，2007，11：1250－1251.

［109］Subramaniam D，Ramalingam S，May R，et al.Gastrin－mediated interleukin－8and cyclooxygenase－2 gene expression：differential transcriptional and posttranscriptional mechanisms.Gastroenterology，2008，134（4）：1070－1082.

［110］Konturek P C，Konturek S J，Brzozowski T.Gastric cancer and Helicobacter pylori infection.J Physiol Pharmacol，2006，57（Suppl 3）：51－65.

［111］Soh K，Yanagisawa A，Hiratsuka H，et al.Variation in K－ras codon 12point mutation rate with histological atypia within individual colorectal tumors.Jpn J Cancer Res，1993，84（4）：388－393.

［112］顾华丽，董静.胃癌组织中H－ras及K－ras基因第12密码子点突变的检测及意义.青岛大学医学院学报，2006，42（1）：56－60.

［113］Hunt J D，Mera R，Strimas A，et al.K－ras mutations are not predictive for progression of preneoplastic gastric lesions.Cancer Epidemiol Biomarkers Prev，2001，10（1）：79－80.

［114］Schubbert S，Shannon K，Bollag G.Hyperactive Ras in developmental disorders and cancer.Nat Rev Cancer，2007，7（4）：295－308.

［115］Kim M A，Lee H S，Lee H E，et al.EGFR in gastric carcinomas：prognostic significance of protein overexpression and high gene copy number.Histopathology，2008，52（6）：738－746.

［116］Morrison H，Sperka T，Manent J，et al.Merlin／neurofibromatosis type 2suppresses growth by inhibiting the activation of Ras and Rac.Cancer Res，2007，67（2）：520－527.

［117］Orian－Rousseau V，Morrison H，Matzke A，et al.Hepatocyte growth factor－induced Ras activation requires ERM proteins linked to both CD44v6and F－actin.Mol Biol Cell，2007，18（1）：76－83.

［118］Lam E K，Wang X，Shin V Y，et al.A microRNA contribution to aberrant Ras activation in gastric cancer.Am J Transl Res，2011，3（2）：209－218.

［119］Keates S，Sougioultzis S，Keates A C，et al.cag＋Helicobacter pylori induce transactivation of the epidermal growth factor receptor in AGS gastric epithelial cells.J Biol Chem，2001，276（51）：48127－48134.

［120］Sarbia M，Porschen R，Borchard F，et al.p53protein expression and prognosis in squamous cell carcinoma of the esophagus.Cancer，1994，74（8）：2218－2223.

［121］Petitjean A，Mathe E，Kato S，et al.Impact of mutant p53functional properties on TP53mutation patterns and tumor phenotype：lessons from recent developments in the IARC TP53database.Hum Mutat，2007，28（6）：622－629.

［122］Mattar R，Nonogaki S，Silva C，et al.P53and Rb tumor suppressor gene alterations in gastric cancer.Rev Hosp Clin Fac Med Sao Paulo，2004，59（4）：172－180.

［123］Fenoglio－Preiser C M，Wang J，Stemmermann G N，et al.TP53and gastric carcinoma：a review.Hum Mutat，2003，21（3）：258－270.

［124］Uchino S，Noguchi M，Ochiai A，et al.p53mutation in gastric cancer：agenetic model for carcinogenesis is common to gastric and colorectal cancer.Int J Cancer，1993，54（5）：759－764.

［125］Goncalves A R，Carneiro A J，Martins I，et al.Prognostic significance of p53protein expression in early gastric cancer.Pathol Oncol Res，2011，17（2）：349－355.

［126］Shen H，Solari A，Wang X，et al.P53codon 72polymorphism and risk of gastric cancer in a Chinese population.Oncol Rep，2004，11（5）：1115－1120.

［127］Kim J M，Lee O Y，Lee C G，et al.p53Codon 72and 16－bp duplication polymorphisms of gastric cancer in Koreans，.Korean J Gastroenterol，2007，50（5）：292－298.

［128］Serrano M，Hannon G J，Beach D.A new regulatory motif in cell－cycle control causing specific inhibition of cyclin D／CDK4.Nature，1993，366（6456）：704－707.

［129］Kamb A，Gruis N A，Weaver－Feldhaus J，et al.A cell cycle regulator potentially involved in genesis of many tumor types.Science，1994，264（5157）：436－440.

［130］Otterson G A，Kratzke R A，Coxon A，et al.Absence of p16INK4protein is restricted to the subset of lung cancer lines that retains wildtype RB.Oncogene，1994，9（11）：3375－3378.

［131］Newcomb E W，Alonso M，Sung T，et al.Incidence of p14ARF gene deletion in high－grade adult and pediatric astrocytomas.Hum Pathol，2000，31（1）：115－119.

［132］Ding Y，Le XP，Zhang Q X，et al.Methylation and mutation analysis of p16gene in gastric cancer.World J Gastroenterol，2003，9（3）：423－426.

［133］He X S，Su Q，Chen Z C，et al.Expression，deletion［was deleton］and mutation of p16gene in human gastric cancer.World J Gastroenterol，2001，7（4）：515－521.

［134］范开席，王哲海，胡伟.p16、CD44V6和nm23－H1基因在胃癌中的表达.中华消化杂志，2001，21（6）：375－376.

［135］Hino R，Uozaki H，Murakami N，et al.Activation of DNA methyltransferase 1by EBV latent membrane protein 2Aleads to promoter hypermethylation of PTEN gene in gastric carcinoma.Cancer Res，2009，69（7）：2766－2774.

［136］Waite K A，Eng C.Protean PTEN：form and function.Am J Hum Genet，2002，70（4）：829－844.

［137］Zhang B G，Li J F，Yu B Q，et al.microRNA－21promotes tumor proliferation and invasion in gastric cancer by targeting PTEN.Oncol Rep，2012，27（4）：1019－1026.

［138］Xiong X，Ren H Z，Li M H，et al.Down－regulated miRNA－214induces a cell cycle G1arrest in gastric cancer cells by up－regulating the PTEN protein.Pathol Oncol Res，2011，17（4）：931－937.

［139］Yang Z，Yuan X G，Chen J，et al.Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380in gastric cancer tissues：A novel mechanism of PTEN inactivation.Clin Res Hepatol Gastroenterol，2013，37（1）：72－79.

［140］Wang D S，Rieger－Christ K，Latini J M，et al.Molecular analysis of PTEN and MXI1in primary bladder carcinoma.Int J Cancer，2000，88（4）：620－625.

［141］Parkin D M.Global cancer statistics in the year 2000.Lancet Oncol，2001，2（9）：533－543.

［142］Chen X Y，van Der Hulst R W，Shi Y，et al.Comparison of precancerous conditions：atrophy and intestinal metaplasia in Helicobacter pylori gastritis among Chinese and Dutch patients.J Clin Pathol，2001， 54（5）：367－370.

［143］Kondo K，Yao M，Kobayashi K，et al.PTEN／MMAC1／TEP1mutations in human primary renal－cell carcinomas and renal carcinoma cell lines.Int J Cancer，2001，91（2）：219－224.

［144］Koul D，Parthasarathy R，Shen R，et al.Suppression of matrix metalloproteinase－2gene expression and invasion in human glioma cells by MMAC／PTEN.Oncogene，2001，20（46）：6669－6678.

［145］Huang J，Kontos C D.PTEN modulates vascular endothelial growth factor－mediated signaling and angiogenic effects.J Biol Chem，2002，277（13）：10760－10766.

［146］Byzova T V，Goldman C K，Pampori N，et al.A mechanism for modulation of cellular responses to VEGF：activation of the integrins.Mol Cell，2000，6（4）：851－860.

［147］Bao R，Connolly D C，Murphy M，et al.Activation of cancer－specific gene expression by the survivin promoter.J Natl Cancer Inst，2002，94（7）：522－528.

［148］Wenying Z，Zhaoning J，Zhimin Y，et al.Survivin siRNA inhibits gastric cancer in nude mice.Cell Biochem Biophys，2012，62（2）：337－341.

［149］Tamm I，Wang Y，Sausville E，et al.IAP－family protein survivin inhibits caspase activity and apoptosis induced by Fas（CD95），Bax，caspases，and anticancer drugs.Cancer Res，1998，58（23）：5315－5320.

［150］Shin S，Sung B J，Cho Y S，et al.An anti－apoptotic protein human survivin is a direct inhibitor of caspase－3and－7.Biochemistry，2001，40（4）：1117－1123.

［151］Cao W，Fan R，Wang L，et al.Expression and regulatory function of miRNA－34ain targeting survivin in gastric cancer cells.Tumour Biol，2012.

［152］邓昊，黄萱，高友晶，等.IFN－γ对人胃腺癌Survivin分子通路的调控作用.世界华人消化杂志，2010，18（30）：3249－3253.

［153］Deng H，Zhen H，Fu Z，et al.The antagonistic effect between STAT1and Survivin and its clinical significance in gastric cancer.Oncol Lett，2012，3（1）：193－199.

［154］Akiyama T，Sudo C，Ogawara H，et al.The product of the human c－erbB－2gene：a 185－kilodalton glycoprotein with tyrosine kinase activity.Science，1986，232（4758）：1644－1646.

［155］Popescu N C，King C R，Kraus M H.Localization of the human erbB－2gene on normal and rearranged chromosomes 17to bands q12－21.32.Genomics，1989，4（3）：362－366.

［156］Tanner M，Hollmen M，Junttila T T，et al.Amplification of HER－2in gastric carcinoma：association with TopoisomeraseⅡalpha gene amplification，intestinal type，poor prognosis and sensitivity to trastuzumab.Ann Oncol，2005，16（2）：273－278.

［157］Rebischung C，Barnoud R，Stefani L，et al.The effectiveness of trastuzumab（Herceptin）combined with chemotherapy for gastric carcinoma with overexpression of the c－erbB－2protein.Gastric Cancer，2005，8（4）：249－252.

［158］Jacobs J J，Scheijen B，Voncken J W，et al.Bmi－1collaborates with c－Myc in tumorigenesis by inhibiting c－Myc－induced apoptosis via INK4a／ARF.Genes Dev，1999，13（20）：2678－2690.

［159］Jacobs J J，Kieboom K，Marino S，et al.The oncogene and Polycomb－group gene bmi－1regulates cell proliferation and senescence through the ink4alocus.Nature，1999，397（6715）：164－168.

［160］张晓伟，秦薇，郭伟剑，等.Bmi－1基因对胃癌细胞增殖的影响及机制.世界华人消化杂志，2009，17 （14）：1390－1393.

［161］Zhang X W，Sheng Y P，Li Q，et al.BMI1and Mel－18oppositely regulate carcinogenesis and progression of gastric cancer.Mol Cancer，2010，9：40.

［162］Hicklin D J，Ellis L M.Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis.J Clin Oncol，2005，23（5）：1011－1027.

［163］Halmaciu I，Gurzu S，Dobreanu M，et al.Preliminary results regarding vascular endothelial growth factor（VEGF－A）levels in the serum of gastric cancer patients.Rev Med Chir Soc Med Nat Iasi，2012，116 （2）：446－451.

［164］Takashima S，Matsushita T，Takayama F，et al.Prognostic significance of magnetic resonance findings in advanced papillary thyroid cancer.Thyroid，2001，11（12）：1153－1159.

［165］Joukov V，Pajusola K，Kaipainen A，et al.A novel vascular endothelial growth factor，VEGF－C，is a ligand for the Flt4（VEGFR－3）and KDR（VEGFR－2）receptor tyrosine kinases.EMBO J，1996，15 （7）：1751.

［166］Cao Y，Linden P，Farnebo J，et al.Vascular endothelial growth factor C induces angiogenesis in vivo.Proc Natl Acad Sci U S A，1998，95（24）：14389－14394.

［167］Amadio M，Scapagnini G，Lupo G，et al.PKCbetaⅡ／HuR／VEGF：A new molecular cascade in retinal pericytes for the regulation of VEGF gene expression.Pharmacol Res，2008，57（1）：60－66.

［168］Essafi－Benkhadir K，Pouyssegur J，Pages G.Implication of the ERK pathway on the post－transcriptional regulation of VEGF mRNA stability.Methods Mol Biol，2010，661：451－469.

［169］Hyde R，Corkins M E，Somers G A，et al.PKC－1acts with the ERK MAPK signaling pathway to regulate Caenorhabditis elegans mechanosensory response.Genes Brain Behav，2011，10（3）：286－298.

［170］He L F，Wang T T，Gao Q Y，et al.Stanniocalcin－1promotes tumor angiogenesis through up－regulation of VEGF in gastric cancer cells.J Biomed Sci，2011，18：39.

［171］Kim D K，Oh S Y，Kwon H C，et al.Clinical significances of preoperative serum interleukin－6and C－reactive protein level in operable gastric cancer.BMC Cancer，2009，9：155.

［172］Liao W C，Lin J T，Wu C Y，et al.Serum interleukin－6level but not genotype predicts survival after resection in stagesⅡandⅢgastric carcinoma.Clin Cancer Res，2008，14（2）：428－434.

［173］Huang S P，Wu M S，Shun C T，et al.Interleukin－6increases vascular endothelial growth factor and angiogenesis in gastric carcinoma.J Biomed Sci，2004，11（4）：517－527.

［174］Zhu B H，Zhan W H，Li Z R，et al.（－）－Epigallocatechin－3－gallate inhibits growth of gastric cancer by reducing VEGF production and angiogenesis.World J Gastroenterol，2007，13（8）：1162－1169.

［175］Loeffler S，Fayard B，Weis J，et al.Interleukin－6induces transcriptional activation of vascular endothelial growth factor（VEGF）in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3and Sp1.Int J Cancer，2005，115（2）：202－213.

［176］Zhu B H，Chen H Y，Zhan W H，et al.（－）－Epigallocatechin－3－gallate inhibits VEGF expression induced by IL－6via Stat3in gastric cancer.World J Gastroenterol，2011，17（18）：2315－2325.

［177］Yu C L，Meyer D J，Campbell G S，et al.Enhanced DNA－binding activity of a Stat3－related protein in cells transformed by the Src oncoprotein.Science，1995，269（5220）：81－83.

［178］Masuda M，Suzui M，Lim J T，et al.Epigallocatechin－3－gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR－related pathways of signal transduction.J Exp Ther Oncol，2002，2（6）：350－359.

［179］Sun P，Yu H，Zhang W Q，et al.Lentivirus－mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.Oncol Rep，2012，28（5）：1687－1692.

［180］Folkman J.Tumor angiogenesis：therapeutic implications.N Engl J Med，1971，285（21）：1182－1186.

［181］Wang Y，Fei D，Vanderlaan M，et al.Biological activity of bevacizumab，a humanized anti－VEGF antibody in vitro.Angiogenesis，2004，7（4）：335－345.

［182］Ferrara N，Hillan K J，Gerber H P，et al.Discovery and development of bevacizumab，an anti－VEGF antibody for treating cancer.Nat Rev Drug Discov，2004，3（5）：391－400.

［183］Wilhelm S M，Carter C，Tang L，et al.BAY 43－9006exhibits broad spectrum oral antitumor activity and targets the RAF／MEK／ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis.Cancer Res，2004，64（19）：7099－7109.

［184］Wedge S R，Ogilvie D J，Dukes M，et al.ZD6474inhibits vascular endothelial growth factor signaling，angiogenesis，and tumor growth following oral administration.Cancer Res，2002，62（16）：4645－4655.

［185］Herbst R S，Hong D，Chap L，et al.Safety，pharmacokinetics，and antitumor activity of AMG 386，a selective angiopoietin inhibitor，in adult patients with advanced solid tumors.J Clin Oncol，2009，27（21）：3557－3565.

［186］Neal J，Wakelee H.AMG－386，a selective angiopoietin－1／－2－neutralizing peptibody for the potential treatment of cancer.Curr Opin Mol Ther，2010，12（4）：487－495.

［187］Chen L，Li T，Li R，et al.Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts.World J Gastroenterol，2006，12（26）：4130－4136.

［188］Staton C A，Brown N J，Rodgers G R，et al.Alphastatin，a 24－amino acid fragment of human fibrinogen，is a potent new inhibitor of activated endothelial cells in vitro and in vivo.Blood，2004，103（2）：601－606.

［189］Koyama Y，Okayama H，Kumamoto K，et al.Overexpression of endoglin（CD105）is associated with recurrence in radically resected gastric cancer.Exp Ther Med，2010，1（4）：627－633.

［190］Tang H L，Hu Y Q，Qin X P，et al.Aplasia ras homolog member I is downregulated in gastric cancer and silencing its expression promotes cell growth in vitro.J Gastroenterol Hepatol，2012，27（8）：1395－1404.

［191］刘爱东，庞久玲，刘士生.胃癌中基质金属蛋白酶－9和CD105表达关系的研究.中国老年学杂志，2009，29（7）：886－887.

［192］Dallas N A，Samuel S，Xia L，et al.Endoglin（CD105）：a marker of tumor vasculature and potential target for therapy.Clin Cancer Res，2008，14（7）：1931－1937.

［193］Tsujie M，Tsujie T，Toi H，et al.Anti－tumor activity of an anti－endoglin monoclonal antibody is enhanced in immunocompetent mice.Int J Cancer，2008，122（10）：2266－2273.

［194］Nakashima H，Natsugoe S，Ishigami S，et al.Clinical significance of nuclear expression of spleen tyrosine kinase（Syk）in gastric cancer.Cancer Lett，2006，236（1）：89－94.

［195］Carter W B，Niu G，Ward M D，et al.Mechanisms of HER－2－induced endothelial cell retraction.Ann Surg Oncol，2007，14（10）：2971－2978.

［196］Peinado H，Olmeda D，Cano A.Snail，Zeb and bHLH factors in tumour progression：an alliance against the epithelial phenotype？Nat Rev Cancer，2007，7（6）：415－428.

［197］Jee Y S，Jang T J，Jung K H.Prostaglandin E（2）and interleukin－1beta reduce E－cadherin expression by enhancing snail expression in gastric cancer cells.J Korean Med Sci，2012，27（9）：987－992.

［198］Hu Z，Liu X，Tang Z，et al.Possible regulatory role of Snail in NF－kappaB－mediated changes in E－cadherin in gastric cancer.Oncol Rep，2013，29（3）：993－1000.

［199］Bachelder R E，Yoon S O，Franci C，et al.Glycogen synthase kinase－3is an endogenous inhibitor of Snail transcription：implications for the epithelial－mesenchymal transition.J Cell Biol，2005，168（1）：29－33.

［200］De Craene B，van Roy F，Berx G.Unraveling signalling cascades for the Snail family of transcription factors.Cell Signal，2005，17（5）：535－547.

［201］Zhou B P，Deng J，Xia W，et al.Dual regulation of Snail by GSK－3beta－mediated phosphorylation in control of epithelial－mesenchymal transition.Nat Cell Biol，2004，6（10）：931－940.

［202］Dominguez D，Montserrat－Sentis B，Virgos－Soler A，et al.Phosphorylation regulates the subcellular location and activity of the snail transcriptional repressor.Mol Cell Biol，2003，23（14）：5078－5089.

［203］Macpherson M R，Molina P，Souchelnytskyi S，et al.Phosphorylation of serine 11and serine 92as new positive regulators of human Snail1function：potential involvement of casein kinase－2and the cAMP－activated kinase protein kinase A.Mol Biol Cell，2010，21（2）：244－253.

［204］Yang Z，Rayala S，Nguyen D，et al.Pak1phosphorylation of snail，a master regulator of epithelial－tomesenchyme transition，modulates snail′s subcellular localization and functions.Cancer Res，2005，65 （8）：3179－3184.

［205］Peinado H，Del C I L C，Olmeda D，et al.A molecular role for lysyl oxidase－like 2enzyme in snail regulation and tumor progression.EMBO J，2005，24（19）：3446－3458.

［206］Vinas－Castells R，Beltran M，Valls G，et al.The hypoxia－controlled FBXL14ubiquitin ligase targets SNAIL1for proteasome degradation.J Biol Chem，2010，285（6）：3794－3805.

［207］Grotegut S，von Schweinitz D，Christofori G，et al.Hepatocyte growth factor induces cell scattering through MAPK／Egr－1－mediated upregulation of Snail.EMBO J，2006，25（15）：3534－3545.

［208］Morita T，Mayanagi T，Sobue K.Dual roles of myocardin－related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling.J Cell Biol，2007，179（5）：1027－1042.

［209］Sahlgren C，Gustafsson M V，Jin S，et al.Notch signaling mediates hypoxia－induced tumor cell migration and invasion.Proc Natl Acad Sci U S A，2008，105（17）：6392－6397.

［210］Wu Y，Zhou B P.TNF－alpha／NF－kappaB／Snail pathway in cancer cell migration and invasion.Br J Cancer，2010，102（4）：639－644.

［211］Julien S，Puig I，Caretti E，et al.Activation of NF－kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition.Oncogene，2007，26（53）：7445－7456.

［212］Mao Z，Ma X，Rong Y，et al.Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E－cadherin via the NF－kappaB pathway.Cancer Sci，2011，102（1）：104－110.

［213］Uchikado Y，Okumura H，Ishigami S，et al.Increased Slug and decreased E－cadherin expression is related to poor prognosis in patients with gastric cancer.Gastric Cancer，2011，14（1）：41－49.

［214］Kang Y，Massague J.Epithelial－mesenchymal transitions：twist in development and metastasis.Cell，2004，118（3）：277－279.

［215］Yang J，Mani S A，Donaher J L，et al.Twist，a master regulator of morphogenesis，plays an essential role in tumor metastasis.Cell，2004，117（7）：927－939.

［216］Yang J，Weinberg R A.Epithelial－mesenchymal transition：at the crossroads of development and tumor metastasis.Dev Cell，2008，14（6）：818－829.

［217］Elias M C，Tozer K R，Silber J R，et al.TWIST is expressed in human gliomas and promotes invasion.Neoplasia，2005，7（9）：824－837.

［218］刘洪义，邢金，所剑.Twist基因沉默对人胃癌SGC7901细胞凋亡的影响.中国老年学杂志，2012，32 （16）：826－828.

［219］刘爱东，庞久玲，郭红辉.基质金属蛋白酶－9在胃癌中的表达及意义.现代中西医结合杂志，2012，21 （13）：1382－1383.

［220］Carneiro F，Oliveira C，Suriano G，et al.Molecular pathology of familial gastric cancer，with an emphasis on hereditary diffuse gastric cancer.J Clin Pathol，2008，61（1）：25－30.

［221］Ghaffari S R，Rafati M，Sabokbar T，et al.A novel truncating mutation in the E－cadherin gene in the first Iranian family with hereditary diffuse gastric cancer.Eur J Surg Oncol，2010，36（6）：559－562.

［222］Simoes－Correia J，Figueiredo J，Lopes R，et al.E－cadherin destabilization accounts for the pathogenicity of missense mutations in hereditary diffuse gastric cancer.PLoS One，2012，7（3）：e33783.

［223］Yang Z，Zhang X，Gang H，et al.Up－regulation of gastric cancer cell invasion by Twist is accompanied by N－cadherin and fibronectin expression.Biochem Biophys Res Commun，2007，358（3）：925－930.

［224］Kamikihara T，Ishigami S，Arigami T，et al.Clinical implications of N－cadherin expression in gastric cancer.Pathol Int，2012，62（3）：161－166.

［225］Ma L，Teruya－Feldstein J，Weinberg R A.Tumour invasion and metastasis initiated by microRNA－10b in breast cancer.Nature，2007，449（7163）：682－688.

［226］Park S M，Gaur A B，Lengyel E，et al.The miR－200family determines the epithelial phenotype of cancer cells by targeting the E－cadherin repressors ZEB1and ZEB2.Genes Dev，2008，22（7）：894－907.

［227］Gregory P A，Bert A G，Paterson E L，et al.The miR－200family and miR－205regulate epithelial to mesenchymal transition by targeting ZEB1and SIP1.Nat Cell Biol，2008，10（5）：593－601.

［228］Hurteau G J，Carlson J A，Spivack S D，et al.Overexpression of the microRNA hsa－miR－200cleads to reduced expression of transcription factor 8and increased expression of E－cadherin.Cancer Res，2007，67（17）：7972－7976.

［229］Korpal M，Lee E S，Hu G，et al.The miR－200family inhibits epithelial－mesenchymal transition and cancer cell migration by direct targeting of E－cadherin transcriptional repressors ZEB1and ZEB2.J Biol Chem，2008，283（22）：14910－14914.

［230］谢乐，姜汉国.miRNA和肿瘤转移的研究进展.医学综述，2009，15：1505－1508.

［231］Resende C，Thiel A，Machado J C，et al.Gastric cancer：basic aspects.Helicobacter，2011，16（Suppl 1）：38－44.